Literature DB >> 10075441

Visual abnormalities in albino wallabies: a brief note.

R W Guillery1, G Jeffery, N Saunders.   

Abstract

Abnormally reduced uncrossed retinofugal pathways and abnormally low retinal cell densities have been described in albinos of a number of species of eutherian mammal, but have not been studied in marsupials. The optic chiasm of marsupials differs from that of the eutherian brains that have been studied, with uncrossed fibres segregating from crossed fibres prechiasmatically in the marsupials, but not in the eutherians. We have examined the optic chiasm and the retina in albino and normally pigmented wallabies (Macropus rufogriseus) to determine whether the abnormalities found in eutherian albinos are also present in this marsupial. The uncrossed pathway of the albino wallaby is smaller than that of the pigmented animals and the cell density in the retinal ganglion cell layer is reduced at the area centralis. We conclude that the characteristic albino abnormalities are present in both groups of mammals in spite of the other known differences in the visual pathways. The albino mutation acts at the chiasm in a similar manner in both groups even though the determinants of the chiasmatic pathway differ.

Entities:  

Mesh:

Year:  1999        PMID: 10075441

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  3 in total

Review 1.  Conversations with Ray Guillery on albinism: linking Siamese cat visual pathway connectivity to mouse retinal development.

Authors:  Carol Mason; Ray Guillery
Journal:  Eur J Neurosci       Date:  2019-04-23       Impact factor: 3.386

2.  Retinal projections to the subcortical visual system in congenic albino and pigmented rats.

Authors:  M D Fleming; R M Benca; M Behan
Journal:  Neuroscience       Date:  2006-09-22       Impact factor: 3.590

3.  Is optic nerve fibre mis-routing a feature of congenital stationary night blindness?

Authors:  T Ung; L E Allen; A T Moore; D Trump; I Zito; A J Hardcastle; J Yates; K Bradshaw
Journal:  Doc Ophthalmol       Date:  2006-03-06       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.